William Blair Issues Negative Estimate for USPH Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Research analysts at William Blair dropped their Q1 2025 earnings estimates for U.S. Physical Therapy in a research report issued on Tuesday, March 11th. William Blair analyst J. Haase now expects that the company will post earnings per share of $0.48 for the quarter, down from their previous estimate of $0.56. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q2 2025 earnings at $0.71 EPS, Q3 2025 earnings at $0.77 EPS, Q4 2025 earnings at $0.76 EPS, FY2025 earnings at $2.73 EPS and FY2026 earnings at $3.05 EPS.

A number of other equities research analysts also recently weighed in on the stock. JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 price target on the stock. Finally, Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $111.50.

U.S. Physical Therapy Stock Down 2.2 %

USPH opened at $77.65 on Thursday. U.S. Physical Therapy has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm’s fifty day moving average price is $86.84 and its two-hundred day moving average price is $87.50. The company has a market capitalization of $1.18 billion, a P/E ratio of 82.60, a P/E/G ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.32%. The ex-dividend date is Friday, March 14th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is currently 97.83%.

Insider Activity

In related news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. CBIZ Investment Advisory Services LLC raised its holdings in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after buying an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of U.S. Physical Therapy in the fourth quarter valued at about $39,000. Venturi Wealth Management LLC raised its holdings in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after buying an additional 704 shares during the last quarter. KBC Group NV raised its holdings in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after buying an additional 315 shares during the last quarter. Finally, Lazard Asset Management LLC bought a new stake in U.S. Physical Therapy during the 4th quarter worth about $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.